Healthcare Industry News: SEEplate
News Release - October 15, 2008
Amedica Receives FDA 510(k) Clearance for SEEplate(TM) Cervical Plate SystemSALT LAKE CITY, Oct. 15 -- (Healthcare Sales & Marketing Network) -- Amedica Corporation, an orthopedic and spinal implants company focused on silicon nitride ceramic technologies, announced today that the U.S. Food and Drug Administration has granted 510(k) marketing clearance to Amedica's SEEplate(TM) Cervical Plate system.
"FDA clearance of our SEEplate Cervical Plate system is another important milestone for Amedica," said Ashok Khandkar, Ph.D., Chief Executive Officer of Amedica Corporation. "This cervical plate system will complement our line of innovative, silicon nitride ceramic spinal spacers, providing surgeons and patients with an important new option for spinal fixation."
Amedica Corporation is an emerging orthopedic implant company focused on using its silicon nitride ceramic technologies to develop and commercialize a broad range of innovative, high-performance spine and joint implants for the growing orthopedic device market. Its products under development include spine, reconstructive hip and knee implants that may represent a new standard of care in total joint implants based on superior durability, performance and safety.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.